Proxy Form for use at the Annual General Meeting to be held on Friday, 27 May 2022 or any adjournment thereof
(1) GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES (2) RE-ELECTION OF DIRECTORS AND CONTINUOUS APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR (3) PROPOSED AMENDMENTS TO THE MEMORANDUM OF ASSOCIATION AND ARTICLES OF ASSOCIATION AND ADOPTION OF NEW MEMORANDUM AND ARTICLES OF ASSOCIATION AND (4) NOTICE OF ANNUAL GENERAL MEETING
VOLUNTARY ANNOUNCEMENT - The first enrollment for confirmatory clinical trials of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System had been completed in China